North America Ruminant Vaccines Market Size, Share & Trends Analysis Report By Animal Type (Cattle, and Sheep & Goats), By Vaccines Type, By Route of Administration, By Indication, By Country and Growth Forecast, 2024 - 2031

North America Ruminant Vaccines Market Size, Share & Trends Analysis Report By Animal Type (Cattle, and Sheep & Goats), By Vaccines Type, By Route of Administration, By Indication, By Country and Growth Forecast, 2024 - 2031


The North America Ruminant Vaccines Market would witness market growth of 5.9% CAGR during the forecast period (2024-2031).

The US market dominated the North America Ruminant Vaccines Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,257.3 million by 2031. The Canada market is experiencing a CAGR of 8% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 7% during (2024 - 2031).

The ruminant vaccines market refers to the segment of the veterinary pharmaceutical industry that focuses on developing, manufacturing, distributing, and selling vaccines specifically designed for ruminant species. Ruminants are a group of mammals with a unique digestive system capable of digesting plant-based diets through rumination. Common ruminant species include cattle (both beef and dairy), sheep, goats, and certain species of deer.

The vaccines are crucial in preventing and controlling a wide range of infectious diseases affecting cattle, sheep, goats, and other ruminant species. These vaccines are utilized in various applications within livestock production systems to safeguard animal health, improve production efficiency, and reduce economic losses. For example, respiratory diseases are a significant concern in ruminant production systems, particularly in intensive or confined housing environments.

With the expansion of the red meat industry in Canada, there is a heightened need for disease prevention and control measures to safeguard the health and productivity of ruminant livestock. The Canadian government states that the country's red meat sector consists of pig, lamb mutton, goat, rabbit, horse, venison, bison, and beef & veal. In 2022, the red meat business had annual shipments of $24.72 billion. There were 1,040,200 sheep and lambs as of 2019. Most of Canada's sheep are produced in Ontario, Quebec, and Alberta (72%). Sheep and lamb farm cash receipts in 2019 totaled $189 million, or 0.3% of overall agricultural cash receipts. Thus, the rising meat industry in the region is driving the market’s growth.

Based on Animal Type, the market is segmented into Cattle, and Sheep & Goats. Based on Vaccines Type, the market is segmented into Modified/ Attenuated Live, Inactivated (Killed), and Others. Based on Route of Administration, the market is segmented into Injectable, and Intranasal. Based on Indication, the market is segmented into Bovine Respiratory Diseases (BRD), Diarrhea/ Scours, FMD, Clostridial Diseases, Leptospirosis, BVD Infection, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled
  • Boehringer Ingelheim International GmbH
  • Zoetis, Inc.
  • Merck & Co., Inc.
  • Bimeda, Inc.
  • Elanco Animal Health, Inc.
  • Virbac
  • Ceva Sante Animale
  • CZ Vaccines S.A.U. (Zendal Health S.A.)
  • Indian Immunologicals Ltd. (National Dairy Development Board)
  • Vaxxinova International BV (EW Group)
North America Ruminant Vaccines Market Report Segmentation

By Animal Type
  • Cattle
  • Sheep & Goats
By Vaccines Type
  • Modified/ Attenuated Live
  • Inactivated (Killed)
  • Others
By Route of Administration
  • Injectable
  • Intranasal
By Indication
  • Bovine Respiratory Diseases (BRD)
  • Diarrhea/ Scours
  • FMD
  • Clostridial Diseases
  • Leptospirosis
  • BVD Infection
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Ruminant Vaccines Market, by Animal Type
1.4.2 North America Ruminant Vaccines Market, by Vaccines Type
1.4.3 North America Ruminant Vaccines Market, by Route of Administration
1.4.4 North America Ruminant Vaccines Market, by Indication
1.4.5 North America Ruminant Vaccines Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Recent strategies deployed in Ruminant Vaccines Market
Chapter 5. North America Ruminant Vaccines Market by Animal Type
5.1 North America Cattle Market by Country
5.2 North America Sheep & Goats Market by Country
Chapter 6. North America Ruminant Vaccines Market by Vaccines Type
6.1 North America Modified/ Attenuated Live Market by Country
6.2 North America Inactivated (Killed) Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Ruminant Vaccines Market by Route of Administration
7.1 North America Injectable Market by Country
7.2 North America Intranasal Market by Country
Chapter 8. North America Ruminant Vaccines Market by Indication
8.1 North America Bovine Respiratory Diseases (BRD) Market by Country
8.2 North America Diarrhea/ Scours Market by Country
8.3 North America FMD Market by Country
8.4 North America Clostridial Diseases Market by Country
8.5 North America Leptospirosis Market by Country
8.6 North America BVD Infection Market by Country
8.7 North America Others Market by Country
Chapter 9. North America Ruminant Vaccines Market by Country
9.1 US Ruminant Vaccines Market
9.1.1 US Ruminant Vaccines Market by Animal Type
9.1.2 US Ruminant Vaccines Market by Vaccines Type
9.1.3 US Ruminant Vaccines Market by Route of Administration
9.1.4 US Ruminant Vaccines Market by Indication
9.2 Canada Ruminant Vaccines Market
9.2.1 Canada Ruminant Vaccines Market by Animal Type
9.2.2 Canada Ruminant Vaccines Market by Vaccines Type
9.2.3 Canada Ruminant Vaccines Market by Route of Administration
9.2.4 Canada Ruminant Vaccines Market by Indication
9.3 Mexico Ruminant Vaccines Market
9.3.1 Mexico Ruminant Vaccines Market by Animal Type
9.3.2 Mexico Ruminant Vaccines Market by Vaccines Type
9.3.3 Mexico Ruminant Vaccines Market by Route of Administration
9.3.4 Mexico Ruminant Vaccines Market by Indication
9.4 Rest of North America Ruminant Vaccines Market
9.4.1 Rest of North America Ruminant Vaccines Market by Animal Type
9.4.2 Rest of North America Ruminant Vaccines Market by Vaccines Type
9.4.3 Rest of North America Ruminant Vaccines Market by Route of Administration
9.4.4 Rest of North America Ruminant Vaccines Market by Indication
Chapter 10. Company Profiles
10.1 Boehringer Ingelheim International GmbH
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional & Segmental Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.1.5.2 Product Launches and Product Expansions:
10.1.5.3 Geographical Expansions:
10.1.6 SWOT Analysis
10.2 Zoetis, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 Recent strategies and developments:
10.2.5.1 Product Launches and Product Expansions:
10.2.6 SWOT Analysis
10.3 Merck & Co., Inc.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Product Launches and Product Expansions:
10.3.6 SWOT Analysis
10.4 Bimeda, Inc.
10.4.1 Company Overview
10.4.2 SWOT Analysis
10.5 Elanco Animal Health, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 SWOT Analysis
10.6 Virbac
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Regional Analysis
10.6.4 SWOT Analysis
10.7 Ceva Sante Animale
10.7.1 Company Overview
10.7.2 Recent strategies and developments:
10.7.2.1 Acquisition and Mergers:
10.7.3 SWOT Analysis
10.8 CZ Vaccines S.A.U. (Zendal Health S.A.)
10.8.1 Company Overview
10.8.2 SWOT Analysis
10.9 Indian Immunologicals Ltd. (National Dairy Development Board)
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Research & Development Expenses
10.9.4 SWOT Analysis
10.10. Vaxxinova International BV (EW Group)
10.10.1 Company Overview
10.10.2 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings